Comparative Analysis of Pharmacopoeia Requirements to Medicinal Plant Raw Materials of the Genus Iris L.

Sandugash Imangaliyevna Ospanova, Gulsim T. Zhumashova, Zuryadda Bektemirovna Sakipova, Ardak Urinbasarovna Tulegenova, Vladimir Sergeevich An, Marat Suleimenov, Fatima Azamatkyzy Otarova, Askhat Almatuly Salykbayev

2025

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.4103/wkmj.wkmj_5_26
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

A BSTRACT In the context of globalization and the growth of the pharmaceutical market, drug quality control and standardization are becoming strategic directions for the pharmaceutical industry’s development. Analyzing the requirements of international pharmacopoeias allows us to develop unified quality indicators for drugs. A comparative analysis of the pharmacopoeial requirements of various countries was carried out to develop a normative document regulating the quality of medicinal plant materials of plants of the genus Iris L. The analysis revealed that monographs on medicinal plant materials of plants of the genus Iris are found in the European Pharmacopoeia (8.0, 2013), the French Pharmacopoeia (11, 2012), the Pharmacopoeia of Ukraine (2.1., 2016), the Pharmacopoeia of China (2005), as well as in the State Pharmacopoeia of the USSR (VIII edition). Furthermore, monographs on plants of the genus Iris are found in several homeopathic pharmacopoeias: the Homeopathic Pharmacopoeia of India, the American Homeopathic Pharmacopoeia, the British Homeopathic Pharmacopoeia, the German Homeopathic Pharmacopoeia, the Taiwan Herbal Pharmacopoeia, as well as in the supplements to the British Pharmacopoeia in the British Pharmaceutical Codex. A comparative analysis of pharmacopoeial monographs has established the pharmacopoeial level of quality and safety requirements for medicinal plant materials of plants of the genus Iris . The analysis has revealed the following main quality indicators for the raw materials of plants of the genus Iris : determination and identification, including macroscopic and microscopic analyses, thin-layer chromatography; determination of total ash and ash insoluble in hydrochloric acid; quantitative determination of the main active substance; requirements for storage conditions and shelf life. As a result of a complete comparative analysis of the information obtained, a draft quality specification for the raw materials of the Kazakhstani Iris species Iris sogdiana and Iris ruthenica will be developed.